hsdd

Understanding Hypoactive Sexual Desire Disorder (HSDD) – Low Libido

In August 2015, Sprout Pharmaceuticals received FDA approval for ADDYI™, known generically as Flibanserin. It is a once-daily, non-hormonal pill. The FDA had twice previously declined to approve this pill, repeatedly requesting further studies. The pill will be used for the treatment of the most common form of sexual dysfunction in premenopausal women, generalized acquired …

Understanding Hypoactive Sexual Desire Disorder (HSDD) – Low Libido Read More »

Finally, women get a “pink pill”!!!! Sprout Pharmaceuticals Receives FDA Approval of ADDYI™!!!!!!!!!!!!!

Sprout Pharmaceuticals receives FDA Approval of ADDYI™!!!!!!!!!!!!! First-ever FDA-approved treatment for women’s most common form of sexual dysfunction, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. HSDD is a persistent absence of sexual thoughts, fantasies, responsiveness and willingness to engage in sexual activity that causes personal or relationship distress and cannot be accounted for by …

Finally, women get a “pink pill”!!!! Sprout Pharmaceuticals Receives FDA Approval of ADDYI™!!!!!!!!!!!!! Read More »

WordPress PopUp Plugin
Scroll to Top

If you want to educate your employees, colleagues, or friends about menopause, look no further!